JPWO2023210732A5 - - Google Patents

Info

Publication number
JPWO2023210732A5
JPWO2023210732A5 JP2024518019A JP2024518019A JPWO2023210732A5 JP WO2023210732 A5 JPWO2023210732 A5 JP WO2023210732A5 JP 2024518019 A JP2024518019 A JP 2024518019A JP 2024518019 A JP2024518019 A JP 2024518019A JP WO2023210732 A5 JPWO2023210732 A5 JP WO2023210732A5
Authority
JP
Japan
Prior art keywords
bacteriophage
genome
accession number
identified
number nite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518019A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023210732A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/016600 external-priority patent/WO2023210732A1/ja
Publication of JPWO2023210732A1 publication Critical patent/JPWO2023210732A1/ja
Publication of JPWO2023210732A5 publication Critical patent/JPWO2023210732A5/ja
Pending legal-status Critical Current

Links

JP2024518019A 2022-04-28 2023-04-27 Pending JPWO2023210732A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022075078 2022-04-28
PCT/JP2023/016600 WO2023210732A1 (ja) 2022-04-28 2023-04-27 バクテリオファージ

Publications (2)

Publication Number Publication Date
JPWO2023210732A1 JPWO2023210732A1 (cg-RX-API-DMAC7.html) 2023-11-02
JPWO2023210732A5 true JPWO2023210732A5 (cg-RX-API-DMAC7.html) 2026-06-12

Family

ID=88518795

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518019A Pending JPWO2023210732A1 (cg-RX-API-DMAC7.html) 2022-04-28 2023-04-27

Country Status (5)

Country Link
EP (1) EP4516898A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023210732A1 (cg-RX-API-DMAC7.html)
AR (1) AR129166A1 (cg-RX-API-DMAC7.html)
TW (1) TW202400783A (cg-RX-API-DMAC7.html)
WO (1) WO2023210732A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4745231A1 (en) * 2023-07-14 2026-05-20 Arrowsmith Inc. MODIFIED BACTERIOPHAGE
CN122060690A (zh) * 2026-04-01 2026-05-19 深圳市百泽诺科生物技术有限公司 一种分枝杆菌噬菌体及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010043924A1 (en) * 1994-04-05 2001-11-22 Exponential Biotherapies, Inc. Antibacterial therapy with bacteriophage physico-chemically altered to delay inactivation by the host defense system
EP2579883A1 (en) * 2010-06-08 2013-04-17 Leah Robert Bacteriophages for use against bacterial infections
EP3358015A1 (en) * 2017-02-03 2018-08-08 Eligo Bioscience Optimized vector for delivery in microbial populations
US11066691B1 (en) * 2018-09-14 2021-07-20 National Technology & Engineering Solutions Of Sandia, Llc Therapeutic phages and methods thereof
US12576118B2 (en) * 2019-05-21 2026-03-17 University of Pittsburgh—of the Commonwealth System of Higher Education Bacteriophages for the treatment of tuberculosis
CN114981408A (zh) * 2019-11-06 2022-08-30 洛可斯生物科学公司 Crispr cas系统和溶原性模块
WO2021092362A1 (en) * 2019-11-07 2021-05-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of specific phages for the treatment of nontuberculous mycobacteria (ntm) infections

Similar Documents

Publication Publication Date Title
James et al. Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa
Mesyanzhinov et al. The genome of bacteriophage φKZ of Pseudomonas aeruginosa
Haas et al. Mixed-linker polymerase chain reaction: a new method for rapid fingerprinting of isolates of the Mycobacterium tuberculosis complex
Njai et al. The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness
O’Hara et al. A highly specific phage defense system is a conserved feature of the Vibrio cholerae mobilome
Garcia et al. The genome sequence of Yersinia pestis bacteriophage φA1122 reveals an intimate history with the coliphage T3 and T7 genomes
Shafer et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient
Lévesque et al. Genomic organization and molecular analysis of virulent bacteriophage 2972 infecting an exopolysaccharide-producing Streptococcus thermophilus strain
Farrar et al. Genome sequence and analysis of a Propionibacterium acnes bacteriophage
JP2024119856A5 (cg-RX-API-DMAC7.html)
Hauser et al. Phylogenetic and molecular analysis of food-borne shiga toxin-producing Escherichia coli
Li et al. Antimicrobial susceptibility and molecular detection of chloramphenicol and florfenicol resistance among Escherichia coli isolates from diseased chickens
JP2015524794A5 (cg-RX-API-DMAC7.html)
JP2023548581A5 (cg-RX-API-DMAC7.html)
Merrill et al. Characterization of Paenibacillus larvae bacteriophages and their genomic relationships to firmicute bacteriophages
Xue et al. The Yersinia phage X1 administered orally efficiently protects a murine chronic enteritis model against Yersinia enterocolitica infection
Bhagchandani et al. Exploring the human virome: composition, dynamics, and implications for health and disease
JP6728120B2 (ja) 新規なバクテリオファージ
Fan et al. Genomic and proteomic features of mycobacteriophage SWU1 isolated from China soil
JPWO2025018295A5 (cg-RX-API-DMAC7.html)
Kumari et al. Characterization of Pseudomonas aeruginosa PAO specific bacteriophages isolated from sewage samples
Pickard et al. Molecular characterization of the Salmonella enterica serovar Typhi Vi-typing bacteriophage E1
AR129166A1 (es) Bacteriófagos con actividad lítica contra mycobacterium
JPWO2020179868A5 (cg-RX-API-DMAC7.html)
WO2025018295A1 (ja) 改変バクテリオファージ